Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC, but targeting mutant KRAS has proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling. Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have demonstrated that genetic ablation of KRAS expression leads to cell cycle arrest and death in cell lines and potent tumor regressions in animal models of PDAC (5–7).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recurrent theme in studies on cancer progression is the increased reliance of cancer cells on OXPHOS in advanced stages of disease.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors revealed a fraction of cells that survive and eventually propagate.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationTransmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationHematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Self-citation
Cited by
Items 801–900 of 1,000
Li, X., Duan, Z., Li, Z., Gu, L., Li, Y., Gong, Q., Gu, Z., & Luo, K. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122294 · Cited by 16
Xu, J., Lina, Z., Du, X., Qi, Z., Chen, S., Zhang, J., Cao, X., & Xia, J. (2023) · Metabolites · doi:10.3390/metabo13111132 · Cited by 17
Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8+ T cells
He, W., Wang, X., Chen, M., Li, C., Chen, W., Pan, L., Cui, Y., Yu, Z., Wu, G., Yang, Y., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1465 · Cited by 17
Dash, S., Ueda, T., Komuro, A., Honda, M., Sugisawa, R., & Okada, H. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06531-x · Cited by 22
Tumor Dormancy and Reactivation: The Role of Heat Shock Proteins
Amissah, H. A., Combs, S. E., & Shevtsov, M. A. (2024) · Cells · doi:10.3390/cells13131087 · Cited by 15
Konaté, M. M., Krushkal, J., Li, M., Chen, L., Kotliarov, Y., Palmisano, A., Pauly, R., Xie, Q., Williams, P. M., McShane, L. M., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05528-6 · Cited by 16
Transformation by different oncogenes relies on specific metabolic adaptations
Peruzzo, P., Comelli, M., Giorgio, E. D., Franforte, E., Mavelli, I., & Brancolini, C. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1215387 · Cited by 17
Models of pancreatic ductal adenocarcinoma
Dennaoui, R., Shrestha, H., & Wagner, K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09989-9 · Cited by 20
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy
Saliakoura, M., & Konstantinidou, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021793 · Cited by 15
Han, H., Wang, D., Yang, M., & Wang, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.7539 · Cited by 14
Metabolic requirements of the metastatic cascade
Drápela, S., & Gomes, A. P. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.100381 · Cited by 20
Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies
Wang, Z., Wu, B., Nie, G., Wei, J., & Li, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216138 · Cited by 18
Vasileva, L. A., Gaynanova, G. A., Kuznetsova, D. A., Valeeva, F. G., Lyubina, A. P., Amerhanova, S. K., Voloshina, A. D., Sibgatullina, G., Samigullin, D., Petrov, K. A., et al. (2023) · Molecules · doi:10.3390/molecules28207229 · Cited by 17
Godfrey, L., Förster, J., Liffers, S., Schröder, C., Köster, J., Henschel, L., Ludwig, K. U., Laehnemann, D., Trajkovic‐Arsic, M., Behrens, D., et al. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01623-z · Cited by 18
Peng, P., Chavel, C. A., Liu, W., Carlson, L. M., Cao, S., Utley, A. T., Olejniczak, S. H., & Lee, K. P. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114445 · Cited by 18
Trace elements in pancreatic cancer
Yanjun, Y., Jing, Z., Yifei, S., Gangzhao, G., Chenxin, Y., Wei, Q., Qiang, Y., & Han, S. (2024) · Cancer Medicine · doi:10.1002/cam4.7454 · Cited by 17
Tumor metabolism as a factor affecting diversity in cancer cachexia
Bathe, O. F. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00677.2024 · Cited by 17
Ma, T., Xie, W., Xu, Z., Gao, W., Zhou, J., Wang, Y., & Chan, F. L. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07460-z · Cited by 19
Self-citationNovel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational Efforts
Bisht, S., & Feldmann, G. (2018) · Oncology Research and Treatment · doi:10.1159/000493437 · Cited by 14
The Intricate Metabolism of Pancreatic Cancers
Camelo, F. S., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_5 · Cited by 18
Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
Connor, A. A., & Gallinger, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1324296 · Cited by 14
Prognostic Significance of Serum Free Amino Acids in Head and Neck Cancers
Všianský, V., Svobodová, M., Gumulec, J., Cernei, N., Štěrbová, D., Zítka, O., Kostřica, R., Smilek, P., Plzák, J., Betka, J., et al. (2019) · Cells · doi:10.3390/cells8050428 · Cited by 15
Yu, Q., Jiang, K., Ma, S., Zheng, Q., Tondi, S., Reina, C., Sabanovic, B., Wen, C., Shen, B.-Y., Aicher, A., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.004 · Cited by 18
Mitochondrial DNA Somatic Mutation in Cancer
Kim, A. (2014) · Toxicological Research · doi:10.5487/tr.2014.30.4.235 · Cited by 17
Xu, Y., Xue, D., Kyani, A., Bankhead, A., Roy, J., Ljungman, M. E., & Neamati, N. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00069 · Cited by 18
Tavares‐Valente, D., Cannone, S., Greco, M. R., Carvalho, T. M. A., Baltazar, F., Queirós, O., Agrimi, G., Reshkin, S. J., & Cardone, R. A. (2023) · Cancers · doi:10.3390/cancers15153868 · Cited by 13
Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment
Zhang, J., Wang, Y., Wang, L., You, L., & Zhang, T. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002758 · Cited by 15
Self-citationQin, Y., Lu, H., Shu, Y., & Wang, J. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c05104 · Cited by 13
G-protein coupled receptors in metabolic reprogramming and cancer
Ahn, S., & Kaipparettu, B. A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108849 · Cited by 17
Autophagy : Moving Benchside Promises to Patient Bedsides
Belaïd, A., Ndiaye, P. D., Filippakis, H., Roux, J., Röttinger, É., Graba, Y., Brest, P., Hofman, P. M., & Mograbi, B. (2015) · Current Cancer Drug Targets · doi:10.2174/156800961508151001102452 · Cited by 13
Wan, J., Cui, J., Wang, L., Wu, K., Hong, X., Zou, Y., Zhao, S., & Hong, K. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0665-1 · Cited by 13
RetractedKnockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells
Yang, L., Ye, F., Zeng, L., Li, Y., & Chai, W. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s234530 · Cited by 15
RetractedPandit, S. K., Sandrini, G., Merulla, J., Nobili, V., Wang, X., Zangari, A., Rinaldi, A., Shinde, D. A., Carbone, G. M., & Catapano, C. V. (2021) · Cancers · doi:10.3390/cancers13236029 · Cited by 13
Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts
Ruess, D. A., Görgülü, K., Wörmann, S. M., & Algül, H. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0453-y · Cited by 15
An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors
Gu, H., Peng, Y., & Chen, Y. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200618123436 · Cited by 15
Crucial Roles of microRNA-Mediated Autophagy in Urologic Malignancies
Shen, M., Li, X., Qian, B., Wang, Q., Lin, S., Wu, W., Zhu, S., Zhu, R., & Zhao, S. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.61175 · Cited by 14
GNAS shifts metabolism in pancreatic cancer
Hollstein, P. E., & Shaw, R. J. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0120-5 · Cited by 13
Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications
Psvv, C., Sunil, S., Thuyyath, N., Kokkanti, R. R., & Lavudi, K. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1741800 · Cited by 15
di Blasio, L., Vara-Messler, M., Peracino, B., Masti, E., Cepas, V., Trusolino, L., Puliafito, A., Bertotti, A., Monica, V., & Primo, L. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08744-8 · Cited by 15
Immune cells in residual disease and recurrence
Ceyhan, Y., Garcia, N. M. G., & Alvarez, J. V. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.04.001 · Cited by 13
Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment
Bonilla, M. E., Radyk, M. D., Perricone, M. D., Elhossiny, A. M., Harold, A. C., Medina-Cabrera, P. I., Kadiyala, P., Shi, J., Frankel, T. L., Carpenter, E. S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.180114 · Cited by 14
Self-citationJü, R., Fei, K., Li, S.-A., Chen, C., Zhu, L., Li, J., Zhang, D., Guo, L., & Ye, C. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.249326 · Cited by 15
Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer
Wu, Z., Lee, Y. F., Yeo, X. H., Loo, S. Y., & Tam, W. L. (2021) · Cancers · doi:10.3390/cancers13061316 · Cited by 16
More challenges ahead—metabolic heterogeneity of pancreatic cancer stem cells
Heeschen, C., & Sancho, P. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1105353 · Cited by 12
Varadhachary, G. R., & Wolff, R. A. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.015586 · Cited by 12
Dujardin, P., Baginska, A. K., Urban, S., & Grüner, B. M. (2021) · Cancers · doi:10.3390/cancers13164187 · Cited by 15
Targeting mitochondria in pancreatic cancer
Errico, A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.143 · Cited by 12
Imaging hamster model of bile duct cancer in vivo using fluorescent l-glucose derivatives
Yokoyama, H., Sasaki, A., Yoshizawa, T., Kijima, H., Hakamada, K., & Yamada, K. (2016) · Human Cell · doi:10.1007/s13577-015-0131-5 · Cited by 14
Long Non-coding RNAs Involved in Metabolic Alterations in Breast and Prostate Cancers
Kamada, S., Takeiwa, T., Ikeda, K., Horie‐Inoue, K., & Inoue, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.593200 · Cited by 13
The big picture: exploring the metabolic cross-talk in cancer
Schulze, A., & Yuneva, M. O. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.036673 · Cited by 13
Bao, X., Hou, B., Guo, Z., Song, L., Chen, H., Zheng, Q., Zhao, Y., Gao, D., Fan, C., Xiong, X., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02992-5 · Cited by 14
Carugo, A., & Draetta, G. F. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1245 · Cited by 12
Self-citationCorrelation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine
Lai, G., Wang, F., Nie, D., Lei, S., Wu, Z., Cao, J., & Tang, L.-L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2192654 · Cited by 15
Bessa, C., Loureiro, J. B., Barros, M. G. R. T., Isca, V. M. S., Sardão, V. A., Oliveira, P. J., Bernardino, R. L., Herman-de-Sousa, C., Costa, M. A., Correia‐de‐Sá, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065710 · Cited by 12
Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity
Khalifa, A., Guijarro, A. I., Ravera, S., Bertola, N., Adorni, M. P., Papotti, B., Raffaghello, L., Benelli, R., Becherini, P., Namatalla, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42652-1 · Cited by 11
UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect
Caggiano, E. G., & Taniguchi, C. M. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10157-4 · Cited by 14
Li, N., Chamkha, I., Verma, G., Swoboda, S., Lindstedt, M., Greiff, L., Elmér, E., & Ehinger, J. K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1304106 · Cited by 16
Choi, H. Y., Zhu, Y., Zhao, X., Mehta, S. N., Hernandez, J. C., Lee, J. J., Kou, Y., Machida, R., Giacca, M., Sal, G. D., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01174-6 · Cited by 11
RetractedA senescence restriction point acting on chromatin integrates oncogenic signals
Lopes‐Paciencia, S., Bourdeau, V., Rowell, M., Amirimehr, D., Guillon, J., Kalegari, P., Barua, A., Trinh, V. Q., Azzi, F., Turcotte, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114044 · Cited by 13
Giglio, E., Giuseffi, M., Picerno, S., Sichetti, M., & Mecca, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010154 · Cited by 11
Lee, H., Lim, S. H., Lee, H., Han, J. M., & Min, D. S. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01446-9 · Cited by 12
Deciphering the dual role and prognostic potential of PINK1 across cancer types
Radin, D., Dai, K., & Leonardi, D. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295314 · Cited by 13
Dang, X., Lei, S., Luo, S., Hu, Y., Wang, J., Zhang, D., Lü, D., Jiang, F., & Fu, L. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105015 · Cited by 12
BRAF-Inhibitor-Induced Metabolic Alterations in A375 Melanoma Cells
Karki, P., Sensenbach, S., Angardi, V., & Orman, M. A. (2021) · Metabolites · doi:10.3390/metabo11110777 · Cited by 14
Kutay, M., Gözüaçık, D., & Çakır, T. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0008 · Cited by 10
Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC
Zhang, X., Yang, L., Deng, Y., Huang, Z., Huang, H., Wu, Y., He, B., & Hu, F. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04882-0 · Cited by 14
Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs
Prabhu, S. S., Nair, A. S., & Nirmala, S. V. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01465-y · Cited by 14
Haastrup, M. O., Vikramdeo, K. S., Anand, S., Khan, M. A., Carter, J. E., Singh, S., Singh, A. P., & Dasgupta, S. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0138 · Cited by 11
Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality
Donahue, T. R., & Dawson, D. W. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.06.009 · Cited by 13
Singh, B., Sarli, V. N., Washburn, L. J., Raythatha, M. R., & Lucci, A. (2018) · Oncotarget · doi:10.18632/oncotarget.24322 · Cited by 11
Mottini, C., & Cardone, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145023 · Cited by 13
Liu, B., Shen, Y., Huang, H., Croce, K. D., Wu, M., Fan, Y., Liu, Y., Xu, J., & Yao, G. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00652-4 · Cited by 12
Autophagy and senescence: Insights from normal and cancer stem cells
Talukdar, S., Das, S. K., Emdad, L., & Fisher, P. B. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.005 · Cited by 13
Zhou, W., Wang, Y., Gao, H., Jia, Y., Xu, Y., Wan, X., Zhang, Z., Yu, H., & Yan, S. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.604730 · Cited by 11
Self-citationMetabolic reprogramming and cancer precision medicine: a narrative review
Zhang, H., & Tang, S. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-21-27 · Cited by 12
Kadonosono, T., Miyamoto, K., Sakai, S., Matsuo, Y., Kitajima, S., Wang, Q., Endo, M., Niibori, M., Kuchimaru, T., Soga, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14272-0 · Cited by 11
Shen, Z., Li, T., & Wang, X. (2018) · Medicine · doi:10.1097/md.0000000000011476 · Cited by 11
Regulation of KRAS4A/B splicing in cancer stem cells by the RBM39 splicing complexPreprint
Chen, W.-C., To, M. D., Westcott, P. M. K., Delrosario, R., Kim, I.-J., Philips, M. R., Tran, Q., Bayani, N., & Balmain, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/646125 · Cited by 11
Slow TCA flux implies low ATP production in tumorsPreprint
Bartman, C., Shen, Y., Lee, W. D., TeSlaa, T. A., Jankowski, C. S. R., Wang, L., Yang, L., Roichman, A., Bhatt, V. D., Lan, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.04.463108 · Cited by 11
Bhandari, K., & Ding, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073958 · Cited by 10
Targeting pivotal amino acids metabolism for treatment of leukemia
Hong, J., Liu, W., Xiao, X., Gajendran, B., & Ben‐David, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40492 · Cited by 11
Hashimoto, A., & Hashimoto, S. (2024) · Cancers · doi:10.3390/cancers16234094 · Cited by 13
Aguilar‐Valdés, A., Noriega, L. G., Tovar, A. R., Ibarra-Sánchez, M. D. J., Sosa‐Hernández, V. A., Maravillas‐Montero, J. L., & Martínez‐Aguilar, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.018 · Cited by 12
Unraveling and targeting RAS-driven metabolic signaling for therapeutic gain
DeLiberty, J. M., Robb, R. N., Gates, C. E., & Bryant, K. L. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.010 · Cited by 11
Mudassar, F., Shen, H. M., Cook, K. M., & Hau, E. K. C. (2022) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.13416 · Cited by 10
Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly
Chu, Y., Chen, C.-W. D., Lai, M., Lim, S., & Lin, W.-R. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i29.4499 · Cited by 13
Cancer stem cells: advances in the glucose, lipid and amino acid metabolism
Kong, W., Gao, Y., Zhao, S., & Yang, H. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04861-6 · Cited by 11
Sugar? No Thank You, Just a Deep Breath of Oxygen for Cancer Stem Cells
Viale, A., & Draetta, G. F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.020 · Cited by 10
Self-citationOn mitochondrial metabolism in tumor biology
Shoshan, M. C. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000336 · Cited by 10
Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
Leppänen, J., Helminen, O., Huhta, H. I., Kauppila, J. H., Isohookana, J., Haapasaari, K., Parkkila, S., Saarnio, J., Lehenkari, P. P., & Karttunen, T. J. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1432-4 · Cited by 12
Buckley, A. M., Dunne, M. R., Morrissey, M. E., Kennedy, S. A., Nolan, A. A., Davern, M., Foley, E. K., Clarke, N. E., Lysaght, J., Ravi, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68777-7 · Cited by 10
Liu, D., Steins, A., Klaassen, R., van der Zalm, A. P., Bennink, R. J., van Tienhoven, G., Besselink, M. G., Bijlsma, M. F., & van Laarhoven, H. W. M. (2020) · Biomedicines · doi:10.3390/biomedicines8110444 · Cited by 10
Ogawa, T., Sasaki, A., Ono, K., Ohshika, S., Ishibashi, Y., & Yamada, K. (2021) · Human Cell · doi:10.1007/s13577-020-00483-y · Cited by 10
Hu, X., Wang, Z., Su, P., Zhang, Q., & Kou, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933248 · Cited by 12
Sanaei, M., Taheri, F., Heshmati, M., Bashash, D., Nazmabadi, R., Faramarz, M.-A., Nahid‐Samiei, M., Shirzad, H., & Bagheri, N. (2021) · Cell Biology International · doi:10.1002/cbin.11651 · Cited by 11
mCAUSE: Prioritizing mitochondrial targets that alleviate pancreatic cancer cell phenotypes
Murata, D., Ito, F., Tang, G., Iwata, W., Yeung, N., West, J. J., Ewald, A. J., Wang, X., Iijima, M., & Sesaki, H. (2024) · iScience · doi:10.1016/j.isci.2024.110880 · Cited by 9
Proteostasis in cellular dormancy: lessons from yeast to oocytes
de Souza, S. R., Böke, E., & Zaffagnini, G. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.05.004 · Cited by 11
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC
Tran, N. L., Jiang, J., Ma, M., Gadbois, G. E., Gulay, K. C. M., Verano, A. L., Schiavon, C. R., Rebollo, E., Zhou, H., Huang, C., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01978-1 · Cited by 17
Poles, M., Pacchiana, R., Mortali, C., Cisterna, B., Mullappilly, N., Celesia, A., Danzi, F., Gaspari, M., Cecconi, D., Donadelli, M., et al. (2025) · FEBS Journal · doi:10.1111/febs.70223 · Cited by 9
Sultana, O. F., Bandaru, M., Bushra, M. A., Reddy, P. H., & Reddy, A. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102957 · Cited by 12
Metadata
- Authors
- Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., Kang, Y., Yuan, M., Asara, J. M., Wang, Y. A., Heffernan, T. P., Kimmelman, A. C., Wang, H., Fleming, J. B., Cantley, L. C., DePinho, R. A., & Draetta, G. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Weill Cornell Medicine (US)
- IRCCS Ospedale San Raffaele (IT)
- Beth Israel Deaconess Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Viale, Andrea
- Draetta, Giulio F.
- ORCID
- Viale, Andrea
- Pettazzoni, Piergiorgio
- Lyssiotis, Costas A.
- Ying, Haoqiang
- Sánchez, Nora
- Marchesini, Matteo
- Carugo, Alessandro
- Seth, Sahil
- Giuliani, Virginia
- Colla, Simona
- Nezi, Luigi
- Genovese, Giannicola
- Deem, Angela K.
- Yao, Wantong
- Brunetto, Emanuela
- Kang, Ya’an
- Yuan, Min
- Asara, John M.
- Wang, Y. Alan
- Heffernan, Timothy P.
- Kimmelman, Alec C.
- Wang, Huamin
- Fleming, Jason B.
- Cantley, Lewis C.
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7524
- Pages
- 628-632
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376130
- OpenAlex
- W2023300506
- Semantic Scholar
- 819eeeb41f6e84dd5c00221a269e91238736c4ad
- Cited by
- 1,259
- References
- 125
- Citations by year
- 2026: 93 · 2025: 72 · 2024: 104 · 2023: 105 · 2022: 119 · 2021: 131 · 2020: 135 · 2019: 114 · 2018: 105 · 2017: 90 · 2016: 99 · 2015: 81 · 2014: 8
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, CA-16672, CA 016672, P01CA120964, P30CA016672, P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, KRAS mutation, tumor recurrence, oxidative phosphorylation, mitochondrial respiration, cancer stem cells, autophagy, glycolysis, OXPHOS inhibitors, combination therapy
- MeSH terms
- Animals, Autophagy, Cell Survival, Disease Models, Animal, Female, Glycolysis, Lysosomes, Mitochondria, Mutation, Neoplasm Recurrence, Local, Oxidative Phosphorylation, Pancreatic Neoplasms, Recurrence, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Genes, p53, Proto-Oncogene Proteins p21(ras), Cell Respiration, Carcinoma, Pancreatic Ductal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.